CN101394857A - 含有寡聚核苷酸和无毒lps的用于治疗癌症的组合物 - Google Patents
含有寡聚核苷酸和无毒lps的用于治疗癌症的组合物 Download PDFInfo
- Publication number
- CN101394857A CN101394857A CNA2006800536116A CN200680053611A CN101394857A CN 101394857 A CN101394857 A CN 101394857A CN A2006800536116 A CNA2006800536116 A CN A2006800536116A CN 200680053611 A CN200680053611 A CN 200680053611A CN 101394857 A CN101394857 A CN 101394857A
- Authority
- CN
- China
- Prior art keywords
- treatment
- compositions
- cancer
- lipopolysaccharide
- odn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/739—Lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (13)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2006/000360 WO2007089051A1 (en) | 2006-02-01 | 2006-02-01 | Composition for treating cancer comprising oligonucleotide and non-toxic lps |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101394857A true CN101394857A (zh) | 2009-03-25 |
Family
ID=38327599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2006800536116A Pending CN101394857A (zh) | 2006-02-01 | 2006-02-01 | 含有寡聚核苷酸和无毒lps的用于治疗癌症的组合物 |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1986664A4 (zh) |
CN (1) | CN101394857A (zh) |
WO (1) | WO2007089051A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2444103T3 (pl) * | 2009-06-19 | 2018-05-30 | Eyegene Inc. | Szczepionka przeciwko rakowi szyjki macicy |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU23178A1 (es) * | 2002-04-15 | 2006-09-22 | Ct Ingenieria Genetica Biotech | INMUNOTERAPIA ACTIVA ANTIANGIOGéNICA |
KR100456681B1 (ko) * | 2002-05-22 | 2004-11-10 | 주식회사 대웅 | 박테리아의 염색체 dna 파쇄물과 비독성리포폴리사카라이드를 포함하는 면역강화 및 조절 조성물 |
CA2388049A1 (en) * | 2002-05-30 | 2003-11-30 | Immunotech S.A. | Immunostimulatory oligonucleotides and uses thereof |
AR040996A1 (es) * | 2002-08-19 | 2005-04-27 | Coley Pharm Group Inc | Acidos nucleicos inmunoestimuladores |
KR100740237B1 (ko) * | 2005-05-10 | 2007-07-18 | 아이진 주식회사 | 올리고뉴클레오타이드 및 비독성 다당체를 포함하는면역보조제 |
-
2006
- 2006-02-01 CN CNA2006800536116A patent/CN101394857A/zh active Pending
- 2006-02-01 EP EP06715813A patent/EP1986664A4/en not_active Withdrawn
- 2006-02-01 WO PCT/KR2006/000360 patent/WO2007089051A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007089051A1 (en) | 2007-08-09 |
EP1986664A4 (en) | 2009-07-22 |
EP1986664A1 (en) | 2008-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2235839T3 (es) | Uso de oligonucleotidos estabilizados para la preparacion de un medicamento de accion antitumoral. | |
EP0855184A1 (en) | Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination | |
CA2621127C (en) | Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms | |
JPH0575731B2 (zh) | ||
PT1511845E (pt) | Oligonucleótidos imuno-estimuladores e suas utilizações | |
MXPA04010415A (es) | Composiciones oligonucleotdias y su uso para la modulacion de respuestas inmunes. | |
KR100456681B1 (ko) | 박테리아의 염색체 dna 파쇄물과 비독성리포폴리사카라이드를 포함하는 면역강화 및 조절 조성물 | |
Bhagat et al. | CpG penta-and hexadeoxyribonucleotides as potent immunomodulatory agents | |
KR100740237B1 (ko) | 올리고뉴클레오타이드 및 비독성 다당체를 포함하는면역보조제 | |
CN101394857A (zh) | 含有寡聚核苷酸和无毒lps的用于治疗癌症的组合物 | |
Cho et al. | A combination of E. coli DNA fragments and modified lipopolysaccharides as a cancer immunotherapy | |
Wagner | Immunobiology of bacterial CpG-DNA | |
Yamamoto et al. | Oligodeoxyribonucleotides with 5′-ACGT-3′ or 5′-TCGA-3′ sequence induce production of interferons | |
EP3218003B1 (en) | Attenuated or inactivated pathogenic escherichia coli for treating urogenital cancer | |
CN114099540A (zh) | 阳离聚合物在制备用于清除肠道微生物毒素以及治疗肿瘤药物的应用 | |
JPH11512076A (ja) | Adp−リボシルトランスフェラーゼ活性を呈する組成物、及びその調製及び使用のための方法 | |
Wang et al. | Screening of novel immunostimulatory CpG ODNs and their anti-leukemic effects as immunoadjuvants of tumor vaccines in murine acute lymphoblastic leukemia | |
KR101452830B1 (ko) | 두 가지 항암물질을 동시에 제공하는 대장균 균주 | |
KR20080107396A (ko) | 올리고뉴크레오타이드 및 비독성 다당체를 포함하는 항암제조성물 | |
CN110218729B (zh) | 一种鸡特异性免疫活化剂CpG-ODN及其应用 | |
CN100508994C (zh) | 无细胞卡介菌粘膜免疫调理剂及其应用 | |
Weeratna et al. | Potential use of CpG ODN for cancer immunotherapy | |
Cho et al. | Bacterial DNA containing methylated CpG motifs retains immunostimulatory activity in synergy with modified lipopolysaccharides | |
KR101101149B1 (ko) | Th1 면역반응을 유발하는 CpG 올리고디옥시뉴클레오타이드 및 그 제작 방법 | |
Teodorczyk-Injeyan et al. | Menningococcal antigens (MA): A novel immune stimulant in experimental neoplasia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: BEAR CO., LTD. Free format text: FORMER OWNER: EGEN CO.,LTD. Effective date: 20090417 |
|
C10 | Entry into substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20090417 Address after: Gyeonggi Do, South Korea Applicant after: Daewoong Co., Ltd. Address before: Seoul, South Kerean Applicant before: Angel company Co-applicant before: Daewoong Co., Ltd. |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090325 |